Genomic Biomarker Tests Endorsed for Early Prostate Cancer Management
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
Researchers propose solutions to underrepresentation of certain groups in genetic databases, based on two recent initiatives.
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
Agilent and Genomenon team up to bring users more effective software and search tools for making a genetic diagnosis.
A glitch in the local run management software may open the door to hacking, agency says.